| Identification | Back Directory | [Name]
Rhodium, tetrakis[μ-[(αR)-4,5,6,7-tetrachloro-1,3-dihydro-1,3-dioxo-α-tricyclo[3.3.1.13,7]dec-1-yl-2H-isoindole-2-acetato-κO2:κO′2]]di-, (Rh-Rh) | [CAS]
2223621-11-0 | [Synonyms]
Rh2(R-TCPTAD)4
Rhodium, tetrakis[μ-[(αR)-4,5,6,7-tetrachloro-1,3-dihydro-1,3-dioxo-α-tricyclo[3.3.1.13,7]dec-1-yl-2H-isoindole-2-acetato-κO2:κO′2]]di-, (Rh-Rh) | [Molecular Formula]
C80H64Cl16N4O16Rh2 | [MOL File]
2223621-11-0.mol | [Molecular Weight]
2110.42 |
| Hazard Information | Back Directory | [Uses]
This dirhodium catalyst developed by the Davies lab can form C-C bonds at the most accessible tertiary C-H position with control of both regioselectivity and absolute configuration. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|